Evidence map›Paper›PMID 36012556›Full record

ArticleInternational journal of molecular sciences2022

Genetic Variation in the

Stephan P Verweij, Remco P H Peters, Arnold Catsburg, Henry J C de Vries, Sander Ouburg, Servaas A Morré

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Stephan P VerweijDepartment of Respiratory Medicine, University Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands.
Remco P H PetersResearch Unit, Foundation for Professional Development, East London 5200, South Africa.ORCID 0000-0003-2124-7275
Arnold CatsburgMolGen B.V., 3905 NL Veenendaal, The Netherlands.
Henry J C de VriesCluster of Infectious Diseases, Public Health Service Amsterdam, 1018 WT Amsterdam, The Netherlands.ORCID 0000-0001-9784-547X
Sander OuburgMicrobe & Lab B.V., 1105 AG Amsterdam, The Netherlands.
Servaas A MorréDepartment of Genetics and Cell Biology, Faculty of Health, Medicine & Life Sciences, Institute of Public Health Genomics, Research Institute GROW, University of Maastricht, 6216 LK Maastricht, The Netherlands.
Foundation for Professional Development · ZAMaastricht University · NLNational Institute for Public Health and the Environment · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to assess the potential association of MBL2 gene single nucleotide polymorphisms (SNPs) to Chlamydia trachomatis infection. We analysed a selected sample of 492 DNA and serum specimens from Dutch Caucasian women. Women were categorized into four groups of infection status based on the results of DNA and antibody tests for C. trachomatis: Ct-DNA+/IgG+, Ct-DNA+/IgG−, Ct-DNA−/IgG+, and Ct-DNA−/IgG−. We compared six MBL2 SNPs (−619G > C (H/L), −290G > C (Y/X), −66C > T (P/Q), +154C > T (A/D), +161A > G (A/B), and +170A > G (A/C)) and their respective haplotypes in relation to these different subgroups. The −619C (L) allele was less present within the Ct-DNA−/IgG+ group compared with the Ct-DNA−/IgG− group (OR = 0.49; 95% CI: 0.28−0.83), while the +170G (C) allele was observed more in the Ct-DNA+/IgG+ group as compared with the Ct-DNA−/IgG− group (OR = 2.4; 95% CI: 1.1−5.4). The HYA/HYA haplotype was more often present in the Ct-DNA−/IgG− group compared with the Ct-DNA+/IgG+ group (OR = 0.37; 95% CI: 0.16−0.87). The +170G (C) allele was associated with increased IgG production (p = 0.048) in C. trachomatis PCR-positive women. This study shows associations for MBL in immune reactions to C. trachomatis. We showed clear associations between MBL2 genotypes, haplotypes, and individuals’ stages of C. trachomatis DNA and IgG positivity.

Indexed as

Chlamydia InfectionsImmunity, HumoralMannose-Binding LectinAntibodies, BacterialChlamydia trachomatisFemaleHaplotypesHumansImmunoglobulin GNetherlandsPolymorphism, Single NucleotideAntibodies, BacterialImmunoglobulin GMannose-Binding LectinMBL2 protein, humanChlamydia trachomatisIgGMBL2 polymorphisms

Identifiers

PMID36012556
PMCPMC9409028
OpenAlexW4293679095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.